ZURA
NASD Zura Bio Limited Class A$4.00 ↑ +0.00 (+0.00%) Trading Up from the previous close of $4.00, $0.12 below the day’s high of $4.12
- YTD change
- -23.66%
- vs 20-day SMA
- -7.00%
- vs 200-day SMA
- -24.77%
Price ranges
Price & Performance
-1.68 (-29.58%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 89.3% away from all-time highs of $37.55
- ZURA is down 24% since the beginning of the year
- ZURA is down 4% over the past 12 months
- ZURA is down 23% over the past 1 month
- 11% of all ZURA investors are betting against ZURA
ZURA reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +3.6%.
- Previous minute
- +$0.00
- Last hour
- +$0.01
- Last 5 days
- -2.68%
- vs 8-day SMA
- -1.84%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Zura Bio Ltd. is a clinical-stage, multi-asset immunology company, which engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded by Someit Sidhu on January 18, 2022 and is headquartered in Henderson, NV.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
